| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |